BMJ  2006;332:3 (7 January), doi:10.1136/bmj.332.7532.3

Editorial

Fundoscopy: to dilate or not to dilate?

The risk of precipitating glaucoma with mydriatic eye drops is very small

Fundoscopy is commonly used by non-ophthalmologists to screen for diabetic retinopathy.¹ The sensitivity of fundoscopy through a dilated pupil for detecting diabetic retinopathy is twice as high as detection through an undilated pupil,² but surveys of general practitioners have found that only 1 in 250 regularly dilate pupils, even when assessing patients at high risk of diabetic eye disease.³ A common reason for not dilating pupils is concern about the risk of precipitating acute angle closure glaucoma.³ How big is this risk?

Recent population based studies indicate that this risk is extremely low. In the Rotterdam study of 6760 people, routine use of mydriatic eye drops in all participants aged 55 and over precipitated acute angle closure glaucoma in only two individuals (0.03%).⁴ The Baltimore eye survey of 4870 people found no cases of acute glaucoma precipitated by mydriasis.⁵ In Australia the Blue Mountains eye study of 3654 people also found no cases of acute angle closure glaucoma resulting from routine pupil dilation (PM, unpublished data). Although some cases may have been missed as participants were not monitored until the effects of mydriasis wore off, the authors of all three studies believe this to be extremely unlikely. Participants in all the studies were given clear instructions to contact the investigators or a medical practitioner immediately if symptoms of acute glaucoma developed, and although several notifications of minor eye irritation were received, none were found to be caused by acute angle closure glaucoma, other than the two cases in the Rotterdam study. Cross checking with doctors and ophthalmologists in the study areas also did not reveal any extra cases of mydriatic induced acute glaucoma in study participants.^{4 5}

A systematic review reported that out of an estimated 600 000 individuals who received mydriatic eye drops, 33 (0.006%) developed acute angle closure glaucoma, giving an estimated risk of 1 in 20 000.⁶ The same review found that in almost 4000 people whose pupils were dilated using tropicamide, none developed acute glaucoma as a result of the dilatation. We are aware of only two cases of tropicamide-induced angle closure glaucoma from the published literature.⁷ Thus, these studies place the risk of acute angle closure glaucoma caused by pharmacological pupil dilation at 1 to 6 per 20 000 people in the general population.

Even in traditional high risk groups, the risk of precipitating acute glaucoma with mydriatic eye drops has been found to be very low. In 13 studies involving over 1000 people with chronic open angle glaucoma, none developed acute glaucoma after mydriasis (0%).⁶ In the Rotterdam study one out of 149 subjects (0.7%) with flat anterior chambers on slit lamp examination developed acute glaucoma after mydriasis,⁴ while in the Baltimore eye survey, all of the 38 subjects determined by an ophthalmologist to have potentially occludable angles were dilated without incident, although 10 had received laser iridotomy before dilation.⁵ These two studies also found that the predictive value of a history of open angle glaucoma or a flat anterior chamber in predicting acute angle closure glaucoma after mydriasis was extremely low (< 1%). The authors of both studies recommend that in a primary care setting warning patients to seek immediate treatment if symptoms of acute glaucoma develop would be more effective than screening for potentially occludable angles.^{4 5}

Few published data exist on Asian populations, whose risk of angle closure is believed to be higher, but a study of 1232 Chinese Singaporeans, where none developed acute glaucoma after mydriasis, puts the risk in Chinese Asians at less than 1 in 1000.⁸ In another study in 2400 Malay Singaporeans one participant developed acute glaucoma, giving a risk of 1 in 2400 in Malay Asians.⁹

There are good pathophysiological reasons why mydriasis is unlikely to lead to acute glaucoma. Pupil block, the underlying mechanism in acute angle closure, is believed to occur when the pupil is in the mid-dilated position, rather than a fully dilated position.¹⁰ In fact, the pupil is in a mid-dilated position in dimly lit environments, which paradoxically suggests that being in a darkened room poses more risk in terms of precipitating acute glaucoma than instilling mydriatic eye drops.

Pupil dilation is important for thorough fundoscopy, and the risk of precipitating acute angle closure glaucoma with routine use of mydriatics is close to zero. Tropicamide 0.5% is a safe agent for use in primary care.⁶ While patients should certainly be warned to seek medical attention if the symptoms of acute angle closure glaucoma (red painful eye, blurry vision, nausea and vomiting) occur, both the patient and doctor should rest assured that this possibility is extremely slight.

Centre for Vision Research, Department of Ophthalmology (Westmead Hospital), Westmead Millennium Institute, University of Sydney, Australia and Vision Co-operative Research Centre
(gerald_liew{at}yahoo.com.au)

Centre for Vision Research, Department of Ophthalmology (Westmead Hospital), Westmead Millennium Institute, University of Sydney, Australia and Vision Co-operative Research Centre

Centre for Eye Research Australia, University of Melbourne, Victoria, Australia

---

Competing interests: None declared.

References

1. Frank RN. Diabetic retinopathy. N Engl J Med 2004;350: 48-8.[Free Full Text]
2. Klein R, Klein BE, Neider MW, Hubbard LD, Meuer SM, Brothers RJ. Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology 1985;92: 485-91.[ISI][Medline]
3. Adaamson E, Herman W. Patterns of medical care for diabetics in the San Francisco Bay area. Atlanta: Centers for Disease Control, 1988.
4. Wolfs RC, Grobbee DE, Hofman A, de Jong PT. Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: the Rotterdam Study. Investigative Ophthalmology Visual Sci 1997;38: 2683-7.[Abstract/Free Full Text]
5. Patel KH, Javitt JC, Tielsch JM, Street DA, Katz J, Quigley HA, et al. Incidence of acute angle-closure glaucoma after pharmacologic mydriasis. Am J Ophthalmology 1995;120: 709-17.[ISI][Medline]
6. Pandit RJ, Taylor R. Mydriasis and glaucoma: exploding the myth. A systematic review. Diabetic Med. 2000;17: 693-9.[CrossRef][ISI][Medline]
7. Brooks AM, West RH, Gillies WE. The risks of precipitating acute angle-closure glaucoma with the clinical use of mydriatic agents. Med J Aust 1986;145: 34-6.[ISI][Medline]
8. Foster PJ, Oen FT, Machin D, Ng TP, Devereux JG, Johnson GJ, et al. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol 2000;118: 1105-11.[Abstract/Free Full Text]
9. Wong TY, Saw SM, Tan DTH. The Singapore Malay eye study. Am J Ophthalmology 2005;139: S13.
10. Mapstone R. Mechanics of pupil block. Br J Ophthalmology 1968;52: 19-25.[Free Full Text]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Funduscopy: to dilate or not?: Precipitation of angle closure may not be a disservice

Kanchan J Bhan, Andrew Bastawrous, and Keith G Davey
BMJ 2006 332: 179. [Extract] [Full Text]

Funduscopy: to dilate or not?: Other drugs can cause partial pupil dilatation

Peter D Cackett
BMJ 2006 332: 179. [Extract] [Full Text]

Doing things differently

Fiona Godlee
BMJ 2006 332: 0. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Bhan, K. J, Bastawrous, A., Davey, K. G (2006). Funduscopy: to dilate or not?: Precipitation of angle closure may not be a disservice. BMJ 332: 179-179 [Full text]  
• Cackett, P. D (2006). Funduscopy: to dilate or not?: Other drugs can cause partial pupil dilatation. BMJ 332: 179-179 [Full text]  

Rapid Responses:

Read all Rapid Responses

The risks of partial pupil dilation with other pharmacological agents

Peter D Cackett
bmj.com, 9 Jan 2006 [Full text]

Diagnosis of acute angle closure glaucoma

Ranjan Rajendram
bmj.com, 10 Jan 2006 [Full text]

First do no harm

Miss Roxane J. Hillier, et al.
bmj.com, 16 Jan 2006 [Full text]

Fundoscopy: to dilate or not to dilate? Precipitation of angle closure may not be a disservice…

Kanchan J Bhan, et al.
bmj.com, 12 Jan 2006 [Full text]

Other reasons for don-dilatation

Anthony E J Fitchett
bmj.com, 13 Jan 2006 [Full text]

The Importance of Pupillary Dilatation in Ophthalmoscopy

Mohammad T Masoud
bmj.com, 13 Jan 2006 [Full text]

The real reason for not dilating?

Scott G Fraser
bmj.com, 17 Jan 2006 [Full text]

Safety of pharmacological dilation of the pupil

Paul J Foster, et al.
bmj.com, 18 Jan 2006 [Full text]

Dilated fundoscopy is important and may be performed by optometrists

Ian E Murdoch, et al.
bmj.com, 25 Jan 2006 [Full text]

The risk / benefit ratio of precipitating Angle Closure Glaucoma by systemic medications also needs to be considered.

Richard P Gale, et al.
bmj.com, 26 Jan 2006 [Full text]

Risk of precipitating glaucoma with mydriatic eye drops in Singaporeans

Srinivasan Sanjay, et al.
bmj.com, 28 Jan 2006 [Full text]

Eclipse sign to detect shallow anterior chamber

Deepa R Anijeet, et al.
bmj.com, 5 Feb 2006 [Full text]

Angle-closure in Asians is predominatly asymptomatic

Paul J Foster
bmj.com, 9 Feb 2006 [Full text]

Authors' Response

Gerald Liew, et al.
bmj.com, 9 Feb 2006 [Full text]